These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2029088

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tubulin expression in melanocytic skin tumors. An immunohistochemical study.
    Smolle J, Soyer HP, Kerl H.
    Am J Dermatopathol; 1990 Feb; 12(1):17-24. PubMed ID: 2316812
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diagnostic and prognostic role of galectin 3 expression in cutaneous melanoma.
    Abdou AG, Hammam MA, Farargy SE, Farag AG, El Shafey EN, Farouk S, Elnaidany NF.
    Am J Dermatopathol; 2010 Dec; 32(8):809-14. PubMed ID: 20885286
    [Abstract] [Full Text] [Related]

  • 5. Nuclear parameters in the superficial and deep portion of melanocytic lesions--a morphometrical investigation.
    Smolle J, Soyer HP, Juettner FM, Hoedl S, Kerl H.
    Pathol Res Pract; 1988 Jun; 183(3):266-70. PubMed ID: 3420029
    [Abstract] [Full Text] [Related]

  • 6. Cytoskeleton and motility: an immunohistological and computer simulation analysis of melanocytic skin tumors.
    Fink-Puches R, Smolle J.
    J Cutan Pathol; 1993 Apr; 20(2):130-6. PubMed ID: 8320357
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reticulin and NM23 staining in the interpretation of lymph nodal nevus rests.
    Kanner WA, Barry CI, Smart CN, Frishberg DP, Binder SW, Wick MR.
    Am J Dermatopathol; 2013 Jun; 35(4):452-7. PubMed ID: 23694823
    [Abstract] [Full Text] [Related]

  • 9. Differential expression of metallopanstimulin/S27 ribosomal protein in melanocytic lesions of the skin.
    Santa Cruz DJ, Hamilton PD, Klos DJ, Fernandez-Pol JA.
    J Cutan Pathol; 1997 Oct; 24(9):533-42. PubMed ID: 9404850
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential expression of epidermal growth factor receptor in melanocytic tumours demonstrated by immunohistochemistry and mRNA in situ hybridization.
    Sparrow LE, Heenan PJ.
    Australas J Dermatol; 1999 Feb; 40(1):19-24. PubMed ID: 10098284
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
    Böni R, Burg G, Doguoglu A, Ilg EC, Schäfer BW, Müller B, Heizmann CW.
    Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
    [Abstract] [Full Text] [Related]

  • 14. In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.
    Schmid P, Itin P, Rufli T.
    Carcinogenesis; 1995 Jul; 16(7):1499-503. PubMed ID: 7614683
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of two morphologic parameters concerning tumor-stroma interaction in benign and malignant melanocytic skin lesions.
    Fink-Puches R, Smolle J, Hofmann-Wellenhof R, Kerl H.
    Am J Dermatopathol; 1998 Oct; 20(5):468-72. PubMed ID: 9790107
    [Abstract] [Full Text] [Related]

  • 17. Alpha-smooth muscle actin expression in tumor and stromal cells of benign and malignant human pigment cell tumors.
    Tsukamoto H, Mishima Y, Hayashibe K, Sasase A.
    J Invest Dermatol; 1992 Jan; 98(1):116-20. PubMed ID: 1728635
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.